» Authors » Wilhelm Woessmann

Wilhelm Woessmann

Explore the profile of Wilhelm Woessmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 89
Citations 1602
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Te Vrugt M, Wessolowski J, Randau G, Alfert A, Mueller S, Scholten K, et al.
Blood . 2024 Jul; 144(13):1412-1417. PMID: 39024510
T-cell lymphoblastic lymphoma (T-LBL) and T-cell acute lymphoblastic leukemia (T-ALL) have common and distinguishing clinical and molecular features. Molecular prognostic factors are needed for T-LBL. We assessed the prevalence and...
2.
Riquelme A, Werner J, Zimmermann M, von Mersi H, Kabickova E, Ceppi F, et al.
Pediatr Blood Cancer . 2024 Jul; 71(9):e31182. PMID: 38961598
Background: Spinal cord compression is a rare presentation of non-Hodgkin lymphoma (NHL) in children. We aimed to describe the prevalence, histological subtypes, clinical presentation, therapy, and outcome of those children...
3.
Luedersen J, Zur Stadt U, Richter J, Oschlies I, Klapper W, Rosenwald A, et al.
Br J Haematol . 2024 Jan; 204(5):1894-1898. PMID: 38279625
Frequency, distribution and prognostic meaning of ALK-partner genes other than NPM1 in ALK-positive anaplastic large-cell lymphoma (ALCL) are unknown. Forty-nine of 316 ALCL diagnosed in the NHL-BFM study group showed...
4.
Hauch R, Hinrichs M, Ruhwald R, Schrum J, Rutkowski S, Woessmann W, et al.
Klin Padiatr . 2023 Apr; 235(3):e1-e2. PMID: 37044121
No abstract available.
5.
Rigaud C, Knorr F, Brugieres L, Woessmann W
Best Pract Res Clin Haematol . 2023 Mar; 36(1):101444. PMID: 36907641
Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a CD30-positive T cell lymphoma characterized by signalling from constitutively activated ALK fusion proteins. Most children and adolescents present in...
6.
Beishuizen A, Mellgren K, Andres M, Auperin A, Bacon C, Bomken S, et al.
Lancet Haematol . 2023 Mar; 10(3):e213-e224. PMID: 36858678
The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and...
7.
Hauch R, Hinrichs M, Ruhwald R, Schrum J, Rutkowski S, Woessmann W, et al.
Klin Padiatr . 2023 Feb; 235(3):159-166. PMID: 36848939
Background: Infections are a major concern for immunocompromised children. We investigated whether non-pharmaceutical interventions (NPIs) implemented in the general population during the coronavirus disease 2019 (COVID-19) pandemic in Germany had...
8.
Heinz A, Calkoen F, Derbich A, Miltner L, Seitz C, Doering M, et al.
Haematologica . 2023 Feb; 108(8):2080-2090. PMID: 36794500
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the scalability...
9.
Knorr F, Schellekens K, Schoot R, Landman-Parker J, Teltschik H, Forster J, et al.
Haematologica . 2022 Dec; 108(5):1442-1446. PMID: 36519329
No abstract available.
10.
Au-Yeung R, Arias Padilla L, Zimmermann M, Reinke S, Oschlies I, Escherich G, et al.
Leukemia . 2022 Nov; 37(2):488-491. PMID: 36352192
No abstract available.